IRIS
Paciotti, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.891
AS - Asia 2.547
SA - Sud America 760
EU - Europa 560
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 73
OC - Oceania 9
Totale 6.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.759
SG - Singapore 1.400
BR - Brasile 590
CN - Cina 457
VN - Vietnam 389
IT - Italia 161
HK - Hong Kong 83
AR - Argentina 74
GB - Regno Unito 61
CA - Canada 54
DE - Germania 52
FI - Finlandia 51
FR - Francia 48
IE - Irlanda 42
IN - India 38
BD - Bangladesh 36
MX - Messico 34
EC - Ecuador 33
ID - Indonesia 29
NG - Nigeria 21
NL - Olanda 21
RU - Federazione Russa 20
ZA - Sudafrica 18
CO - Colombia 17
IQ - Iraq 16
UA - Ucraina 16
VE - Venezuela 14
AT - Austria 11
CH - Svizzera 11
PK - Pakistan 11
SE - Svezia 11
CL - Cile 10
JP - Giappone 10
TR - Turchia 10
AU - Australia 9
PL - Polonia 9
PY - Paraguay 9
ES - Italia 8
MO - Macao, regione amministrativa speciale della Cina 8
UY - Uruguay 8
GT - Guatemala 7
JM - Giamaica 7
TN - Tunisia 7
EG - Egitto 6
MY - Malesia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
NP - Nepal 5
RO - Romania 5
TH - Thailandia 5
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
IL - Israele 4
JO - Giordania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
PS - Palestinian Territory 3
SC - Seychelles 3
BO - Bolivia 2
BS - Bahamas 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LT - Lituania 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
KW - Kuwait 1
LC - Santa Lucia 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
Totale 6.836
Salva come PNG Salva come JPEG
Città #
Singapore 448
San Jose 276
Ashburn 274
Dallas 196
Beijing 147
Ho Chi Minh City 134
Council Bluffs 133
The Dalles 117
Santa Clara 99
Hanoi 89
Shanghai 82
Hong Kong 75
New York 75
Wilmington 75
Chandler 62
Los Angeles 59
Milan 59
Helsinki 51
Dublin 43
São Paulo 42
San Mateo 40
Phoenix 39
Ann Arbor 31
Princeton 31
Boardman 28
Lawrence 24
Paris 24
Rio de Janeiro 24
Da Nang 23
Benin City 21
Buffalo 19
Chicago 18
Orem 18
Brooklyn 17
Haiphong 16
Leawood 16
Guayaquil 15
Mexico City 15
Montreal 14
Hải Dương 13
Naples 13
Seattle 13
Amsterdam 12
Camden 12
London 12
Philadelphia 12
Rome 12
Toronto 12
Belo Horizonte 11
Brasília 11
Johannesburg 11
Atlanta 10
Thái Bình 10
Boston 9
Cincinnati 9
Curitiba 9
Fairfield 9
Houston 9
Warsaw 9
Buenos Aires 8
Denver 8
Frankfurt am Main 8
Las Vegas 8
North Bergen 8
Porto Alegre 8
Quito 8
Biên Hòa 7
Goiânia 7
Manaus 7
Miami 7
Pittsburgh 7
Salvador 7
San Diego 7
Tokyo 7
Beachwood 6
Charlotte 6
Figino 6
Jacksonville 6
Montevideo 6
Osasco 6
Sacramento 6
Secaucus 6
The Bronx 6
Woodbridge 6
Asunción 5
Baghdad 5
Campinas 5
Chennai 5
Columbus 5
Feira de Santana 5
Guarulhos 5
Guatemala City 5
Hortolândia 5
Istanbul 5
Laurinburg 5
Manchester 5
Mumbai 5
Newark 5
Nuremberg 5
Oakland 5
Totale 3.439
Salva come PNG Salva come JPEG
Nome #
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 123
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 120
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 120
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 104
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 99
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 98
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 95
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 95
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 95
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 91
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 89
Effects of a home-based pelvic floor muscle training with and without action and cue observation on urinary incontinence after prostatectomy: A randomized controlled trial 88
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience 87
A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies 86
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 85
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 84
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 83
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study 82
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma 82
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis 81
En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study 81
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer 79
Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging 75
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes 74
External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era 74
Systematic Review and Clinical Outcomes of new Robotic Systems in Urology 73
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer 69
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic? 69
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story 67
Gender-specific risk factors for renal cell carcinoma: a systematic review 66
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study 66
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis 66
Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis 65
Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study 65
A cost analysis in implementing simulation-based training into a novel urology curriculum 65
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure 65
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer 64
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial 64
ROBOT-ASSISTED PARTIAL NEPHRECTOMY: TECHNIQUES AND OUTCOMES FROM THE TRANSATLANTIC ROBOTIC NEPHRON-SPARING SURGERY (TRONES) STUDY GROUP 64
IN VITRO AND IN VIVO NEW EVIDENCE FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE: OPTIMIZATION OF THE STONE FREE RATE (SFR) AFTER RIRS 64
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer in the initial biopsy setting 63
New horizons in gynecological surgery: first-year experience with HUGO™ robotic-assisted surgery system at two tertiary referral robotic centers 62
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes? 61
Assessing the relationship between micro-ultrasound results and pathology at radical prostatectomy 61
Assessment of the diagnostic accuracy of microultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional preliminary experience 60
Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer 59
THE UTILITY OF MICRO-ULTRASOUND IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER: A PRIAS STUDY EXTENSION 59
International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity 58
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes 58
Reply by Authors 57
Assessment of face and content validity of performance metrics for basic robotic surgery skills PBP curriculum: a J-ERUS/YAU consensus on dry-lab training models 57
Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancer 56
Enhanced diagnostic accuracy of micro-ultrasound in prostate cancer detection: An updated series from a single-center prospective study 56
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride 55
A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer 55
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration 53
Surgical Complications Requiring Intervention in Open versus Minimally Invasive Radical Prostatectomy 53
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center 53
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers 53
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 52
Machine learning driven diagnostic pathway for clinically significant prostate cancer: the role of micro-ultrasound 52
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 51
Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers 51
Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment? 51
Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer 50
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic 50
Will Renorrhaphy Become Obsolete? Evaluation of a New Hemostatic Sealant 49
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy 49
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional experience 49
Comparison between the diagnostic accuracy of high resolution micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: Preliminary results from a single-institutional ongoing prospective trial 48
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system 48
High resolution micro-ultrasound imaging for bladder cancer: A gender and stage-oriented assessment. VIDEO 47
Current Landscape of Surgical Assessment Models in Urology Residency Training. Letter 47
A comparative analysis of the HUGOTM robot-assisted surgery system and the Da Vinci® Xi surgical system for robot-assisted sacrocolpopexy for pelvic organ prolapse treatment 47
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative study 46
Profiling of the immune microenvironment in prostate cancer at single cell level 45
Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma 45
HEAD-TO-HEAD COMPARISON BETWEEN MICRO-ULTRASOUND AND MRI IN THE DIFFERENTIATION BETWEEN MUSCLE-INVASIVE AND NON-MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM THE BLADDER MICROUS VERSUS MRI CANCER IMAGING STAGING STUDY (BUS-MISS) PROTOCOL 45
Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis 45
Temporal Trends in the Incidence of Testicular Cancer in the United States over the Past Four Decades 44
Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots 44
UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion 44
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis 43
Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinoma 43
Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer 43
MP36-20 POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER 43
Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center 42
Where Do Micro-Ultrasound and MRI Find Prostate Cancer? A Target Localization Study 42
Transitioning from Da Vinci Si to Xi: assessing surgical outcomes at a high-volume robotic center 42
Beyond the price tag: reassessing the value of robotic surgery in urologic oncology 41
Improving Augmented Reality Through Deep Learning: Real-time Instrument Delineation in Robotic Renal Surgery 41
Robot-Assisted Pyeloplasty with HUGO™ Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center 40
Proficiency-based Progression Training: A Scientific Approach to Learning Surgical Skills 40
Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events 40
Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection 40
Risk factors and reasons for reoperation after radical cystectomy 40
Development and validation of metrics for a new RAPN training model 39
European training in urology (ENTRY): quality-assured training for European urology residents 39
Robot-Assisted Sacropexy with the Novel HUGO Robot-Assisted Surgery System: Initial Experience and Surgical Setup at a Tertiary Referral Robotic Center 38
Initial Experience of Robot-Assisted Simple Prostatectomy with Hugo Robot-Assisted Surgery System: Step-by-Step Description of Two Different Techniques 38
Totale 6.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022114 0 0 0 23 0 1 7 17 18 12 33 3
2022/2023282 51 4 28 24 23 16 7 19 37 31 35 7
2023/2024279 21 22 55 10 11 44 17 26 2 8 21 42
2024/2025882 19 2 21 15 4 65 35 48 113 143 128 289
2025/20263.919 457 255 363 662 231 164 668 214 235 267 179 224
2026/20271.323 258 295 624 146 0 0 0 0 0 0 0 0
Totale 6.978